Study outcomes
TG
The study objectives and endpoints were similar for the main study and fibrate cohorts. Given the small number of patients enrolled in the fibrate cohort (Baseline TG level was defined as the average of randomization day assessment collected predose and the preceding two lipid-qualifying assessments collected during the TG qualifying period. The TG value at week 8 was defined as the average of TG values at week 7 and week 8. In case of missing TG values at week 7 or 8, the non-missing result was used as the week 8 TG value. Responder analysis of TG reduction at various threshold levels was performed, and the proportion of participants with TG normalization (<150 mg dl